Circulating Tumor DNA as a Prognostic Marker in Stage III Colon Cancer

被引：2
|
作者：
Zhao, Zhengyi [1 ]
Cai, Shangli [1 ]
Wang, Zhijie [2 ]
机构：
[1] 3D Med Inc, Med Dept, Shanghai, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Mol Oncol, Dept Med Oncol, Natl Canc Ctr,Canc Hosp, 17 Pan Jia Yuan S Ln, Beijing 100021, Peoples R China
来源：
JAMA ONCOLOGY | 2020年 / 6卷 / 06期
关键词：
D O I：
10.1001/jamaoncol.2020.0283
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：932 / 932
页数：1
相关论文
共 50 条
  • [21] Prognostic effect of tumor location in stage II and III colon cancer.
    Ozveren, Ahmet
    Surmeli, Zeki Gokhan
    Turgut, Asli
    Karaca, Burcak
    Karabulut, Bulent
    Sanli, Ulus Ali
    Uslu, Ruchan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer
    Akagunduz, Baran
    Guven, Deniz Can
    Ozer, Muhammet
    Okten, Ilker Nihat
    Atag, Elif
    Unek, Ilkay Tugba
    Tatli, Ali Murat
    Karaoglu, Aziz
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (02)
  • [23] Circulating tumor DNA as a prognostic biomarker in early stage pancreatic cancer.
    Lee, Belinda
    Lipton, Lara Rachel
    Cohen, Joshua
    Tie, Jeanne
    Javed, Ammar Asrar
    Li, Lu
    Goldstein, David
    Cooray, Prasad
    Nagrial, Adnan
    Burge, Matthew E.
    Tebbutt, Niall C.
    Nikfarjam, Mehrdad
    Harris, Marion
    Lennon, Anne Marie
    Wolfgang, Christopher Lee
    Tomasetti, Cristian
    Papadopoulos, Nickolas
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Gibbs, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [24] PLCRC-PROVENC3 study: Prognostic value of post-surgery liquid biopsy circulating tumor DNA in stage III colon cancer patients
    Rubio-Alarcon, C.
    Franken, I. A.
    van Nassau, S. C. M. W.
    Schraa, S.
    Meiqari, L.
    Ketelaars, S.
    Velculescu, V.
    Angiuoli, S.
    Georgiadis, A.
    Riley, D.
    Greco, C.
    Van Den Broek, D.
    Punt, C. J. A.
    Coupe, V.
    Koopman, M.
    Roodhart, J. M. L.
    Meijer, G.
    Sausen, M.
    Vink, G. R.
    Fijneman, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S427 - S428
  • [25] Circulating tumor DNA as a prognostic marker in colorectal cancer: Preliminary results of a prospective trial
    Laurent-Puig, Pierre
    Bouche, Olivier
    Niarra, Ralph
    Aucouturier, Pascaline
    Benhaim, Leonor
    Landi, Bruno
    Berger, Anne
    Lecomte, Thierry
    Normand, Corinne
    Le Corre, Delphine
    Didelot, Audrey
    Mallet, Karine
    Toralla, Karla Perez
    Hor, Thevy
    El Harrak, Zakaria
    Chatellier, Gilles
    Hutchison, Brian
    Link, Darren
    Taly, Valerie
    CANCER RESEARCH, 2015, 75
  • [26] Circulating tumor DNA (ctDNA) as a prognostic marker for recurrence in resected pancreas cancer.
    Wang, Judy Sing-Zan
    Sausen, Mark
    Parpart-Li, Sonya
    Murphy, Derek M.
    Velculescu, Victor E.
    Wood, Laura D.
    Solt-Linville, Sara
    Sugar, Elizabeth
    Bartlett, Bjarne
    Blair, Cherie
    Dauses, Tianna
    Jaffee, Elizabeth M.
    Hruban, Ralph H.
    Laheru, Dan
    Diaz, Luis A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [27] Circulating Tumor DNA Is an Accurate Diagnostic Tool and Strong Prognostic Marker in Pancreatic Cancer
    Sellahewa, Rav
    Moghaddam, Samar Masoumi
    Lundy, Joanne
    Jenkins, Brendan J.
    Croagh, Daniel
    PANCREAS, 2023, 52 (03) : e188 - e195
  • [28] Circulating tumor cells as prognostic marker in pancreatic cancer
    Yakar, Melek
    Etiz, Durmus
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (02):
  • [29] Thymidylate synthase (TS) expression as a prognostic molecular marker in stage II/III colon cancer
    Klingbiel, Dirk
    Missiaglia, Edoardo
    Yan, Pu
    Tejpar, Sabine
    Roth, Arnaud
    d'Ario, Giovanni
    Delorenzi, Mauro
    Bosman, Fred
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [30] Circulating Tumor DNA in Stage II and III Melanoma
    Brunsgaard, Elise K.
    Bowles, Tawnya L.
    Asare, Elliot A.
    Grossmann, Kenneth
    Boucher, Kenneth M.
    Grossmann, Allie
    Jackson, Julie A.
    Wada, David A.
    Grandemange, Andrew
    Hyngstrom, John R.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 392 - 393
12345